CEFPODOXIME Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefpodoxime, and when can generic versions of Cefpodoxime launch?
Cefpodoxime is a drug marketed by Aurobindo Pharma Ltd, Chartwell Rx, Sun Pharm Inds Ltd, Alkem Labs Ltd, Anda Repository, Aurobindo Pharma, and Sandoz. and is included in eight NDAs.
The generic ingredient in CEFPODOXIME is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefpodoxime
A generic version of CEFPODOXIME was approved as cefpodoxime proxetil by AUROBINDO PHARMA LTD on June 8th, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CEFPODOXIME?
- What are the global sales for CEFPODOXIME?
- What is Average Wholesale Price for CEFPODOXIME?
Summary for CEFPODOXIME
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for CEFPODOXIME |
| DailyMed Link: | CEFPODOXIME at DailyMed |
US Patents and Regulatory Information for CEFPODOXIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | CEFPODOXIME PROXETIL | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 065409-001 | Jun 8, 2007 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Alkem Labs Ltd | CEFPODOXIME PROXETIL | cefpodoxime proxetil | TABLET;ORAL | 210568-001 | May 18, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Rx | CEFPODOXIME PROXETIL | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 090031-002 | Jan 14, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma | CEFPODOXIME PROXETIL | cefpodoxime proxetil | TABLET;ORAL | 065370-002 | Jun 11, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Alkem Labs Ltd | CEFPODOXIME PROXETIL | cefpodoxime proxetil | TABLET;ORAL | 210568-002 | May 18, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
